Trevena Inc on Tuesday said only some doses of its experimental opioid painkiller were found as effective as morphine in two late-stage studies, even though the drug outperformed a placebo – meeting its main study goals.
Trevena’s intravenous formulation, which is designed to extract the pain-reducing potential of an opioid but with fewer side-effects, was tested in patients following a bunion or tummy-tuck surgery.
Source: Reuters
Filed Under: Drug Discovery
